NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Jun Yoshino(Shimane University Hospital), Shin‐ichiro Imai(Washington University in St. Louis), Joseph A. Baur(University of Pennsylvania)
Cited by 1,034
Related Papers
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
|Nature|2000|3.5k
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
|Cell|2001|2.7k
NAD+ and sirtuins in aging and disease
|Trends in Cell Biology|2014|1.4k